Key facts
- Notable investors include Keyhorse Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Minerve Pharmacueticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Minerve Pharmacueticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Minerve Pharmacueticals
Operator of a pharmaceutical company based in Baltimore, Maryland. The company's platform accelerates the creation of first-in-class therapies to inhibit harmful synaptic pruning and focuses on a critical mechanism linked to synapse loss and cognitive decline in conditions such as Alzheimer's and Multiple Sclerosis, enabling business to shape the future of neurodegenerative disease treatment and improve millions of lives globally.
- Sector
- Healthcare
- HQ
- Potomac, MD, United States
- Website
- minervepharma.com/
- Ownership
- Privately Held (backing)
Minerve Pharmacueticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Minerve Pharmacueticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Minerve Pharmacueticals in its N-PORT filings yet. We sweep new filings monthly.